2023 Distinguished Scientist Cornelia M. Weyand, MD, PhD, FAHA

Cornelia M. Weyand, MD, PhD, FAHA
Professor of Medicine and Immunology, Mayo Clinic
Professor Emerita, Stanford University

Cornelia M. Weyand, MD, PhD, is a Professor of Medicine and Immunology at the Mayo Clinic College of Medicine and Science and the Mayo Alix School of Medicine. She holds joint appointments in the Departments of Immunology and Cardiology and leads the Program in Immunity and Inflammation, a translational program bridging basic immunology to disease.

. Weyand earned her MD in Germany, followed by a fellowship at the German Cancer Research Center and a residency at Hannover Medical School, Germany. She subsequently completed a fellowship in Immunology at Stanford University. Dr. Weyand joined Mayo Clinic in 1990, became a Professor of Medicine and Immunology in 1998 and the Barbara Woodward Lips Professor of Medicine & Immunology in 2000. From 2004 to 2009, she was the David Lowance Professor of Medicine at Emory University, where she served as the Director of the Lowance Center for Human Immunology and the Division of Rheumatology. In 2009, she returned to Stanford University, where she became the Chief of Rheumatology and Immunology and the Director of the Center for Translational Medicine. Dr. Weyand remains a faculty member at Stanford University as Professor Emerita.

Dr. Weyand is an elected member of the American Society for Clinical Investigation and the American Association of Physicians. She was named a Notable Woman in Science and Medicine by the Helmholtz Association. The National Institutes of Health have continuously supported her research program since 1993. She has presented forty-four named lectureships and given more than 400 presentations. Her research team has published more than 450 manuscripts. Her current H-index is 138, documenting her wide-reaching impact in the scientific community.

Dr. Weyand’ s contributions to science have followed the arc of how immune responses deviate from host protection to tissue damage. Her primary focus has been on autoimmune diseases; specifically, atherosclerotic disease and the vasculitides.